Literature DB >> 18193305

Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.

L J Wheat1, T J Walsh.   

Abstract

Invasive aspergillosis is a serious and often fatal infection in patients who are neutropenic or have undergone solid organ or stem cell transplantation. Delayed diagnosis and therapy may lead to poor outcomes. Diagnosis may be facilitated by a test for galactomannan antigen detection using an enzyme immunoassay. Other rapid methods for diagnosis include (1-->3)-beta-D: -glucan determination and polymerase chain reaction. The sensitivity and specificity of galactomannan antigenemia testing in serum and bronchoalveolar lavage specimens are high in patients with hematological malignancy, neutropenia, and receipt of stem-cell transplants. False positivity can be seen with concomitant administration of some antibiotics and infection by fungi other than Aspergillus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193305     DOI: 10.1007/s10096-007-0437-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  46 in total

Review 1.  British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Authors:  David W Denning; Christopher C Kibbler; Rosemary A Barnes
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

Review 2.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

3.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Authors:  Johan Maertens; Koen Theunissen; Gregor Verhoef; Johnny Verschakelen; Katrien Lagrou; Eric Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Journal:  Clin Infect Dis       Date:  2005-09-29       Impact factor: 9.079

4.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors:  C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.

Authors:  F Reichenberger; J Habicht; P Matt; R Frei; M Solèr; C T Bolliger; P Dalquen; A Gratwohl; M Tamm
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

6.  Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Françoise Gavini; Huub J M Op den Camp; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.

Authors:  Benjamin Musher; David Fredricks; Wendy Leisenring; S Arunmozhi Balajee; Caitlin Smith; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.

Authors:  William J Steinbach; Rachel M Addison; Lisa McLaughlin; Quincy Gerrald; Paul L Martin; Timothy Driscoll; Christopher Bentsen; John R Perfect; Barbara D Alexander
Journal:  Pediatr Infect Dis J       Date:  2007-07       Impact factor: 2.129

9.  Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.

Authors:  Shahid Husain; David L Paterson; Sean M Studer; Maria Crespo; Joseph Pilewski; Michelle Durkin; Joseph L Wheat; Bruce Johnson; Lisa McLaughlin; Christopher Bentsen; Kenneth R McCurry; Nina Singh
Journal:  Transplantation       Date:  2007-05-27       Impact factor: 4.939

10.  Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.

Authors:  Cornelius J Clancy; Reia A Jaber; Helen L Leather; John R Wingard; Benjamin Staley; L Joseph Wheat; Christina L Cline; Kenneth H Rand; Denise Schain; Maher Baz; M Hong Nguyen
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

View more
  32 in total

Review 1.  Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.

Authors:  Rami Sherif; Brahm H Segal
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

2.  Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.

Authors:  Louis Y A Chai; Bart-Jan Kullberg; Elizabeth M Johnson; Steven Teerenstra; Lay Wai Khin; Alieke G Vonk; Johan Maertens; Olivier Lortholary; Peter J Donnelly; Haran T Schlamm; Peter F Troke; Mihai G Netea; Raoul Herbrecht
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

3.  Fungal endocarditis.

Authors:  George M Varghese; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

4.  The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.

Authors:  Brian T Fisher
Journal:  Curr Fungal Infect Rep       Date:  2013-03-01

5.  Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.

Authors:  Silke Gastine; William Hope; Georg Hempel; Ruta Petraitiene; Vidmantas Petraitis; Diana Mickiene; John Bacher; Thomas J Walsh; Andreas H Groll
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

6.  The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.

Authors:  G Metan; C Ağkuş; H Buldu; A N Koç
Journal:  Infection       Date:  2010-03-17       Impact factor: 3.553

7.  Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.

Authors:  Fang Zheng; Hui Zha; Dandan Yang; Jun Deng; Zhiquan Zhang
Journal:  Mycopathologia       Date:  2016-09-23       Impact factor: 2.574

8.  Improved detection of Histoplasma antigenemia following dissociation of immune complexes.

Authors:  S Swartzentruber; A LeMonte; J Witt; D Fuller; T Davis; C Hage; P Connolly; M Durkin; L J Wheat
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

9.  Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.

Authors:  F Suarez; O Lortholary; S Buland; M T Rubio; D Ghez; V Mahé; G Quesne; S Poirée; A Buzyn; B Varet; P Berche; M E Bougnoux
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

10.  Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.

Authors:  S Husain; C J Clancy; M H Nguyen; S Swartzentruber; H Leather; A M LeMonte; M M Durkin; K S Knox; C A Hage; C Bentsen; N Singh; J R Wingard; L J Wheat
Journal:  Clin Vaccine Immunol       Date:  2008-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.